World's Best Scientists 2026 revealed!
Human Vaccines and Immunotherapeutics
H-index 49

Human Vaccines and Immunotherapeutics

2164-5515

Published by: Taylor & Francis

https://www.tandfonline.com/toc/khvi20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 62 158 220 25
Microbiology 94 140 169 22
Medicine 493 220 339 35

Additional Metrics

Number of Best Scientists*: 625
Documents by Best Scientists*: 747
Top 100 Ranked Scientists*: 16
SCIMAGO H-index: 103
SCIMAGO SJR: 0.897
Impact Factor: 3.5

Overview

Top Research Topics at Human Vaccines & Immunotherapeutics?

Human Vaccines & Immunotherapeutics facilitates discussions on Vaccination, Immunology, Virology, Pediatrics and Immunogenicity. Issues in Vaccination were discussed, taking into consideration concepts from other disciplines like Public health, Immunization, Family medicine and Environmental health. Studies on Family medicine discussed in Human Vaccines & Immunotherapeutics link to the field of Health care.

Immunology studies presented in it focus on topics such as Immune system, Antibody, Antigen, Immunotherapy and Adjuvant. Human Vaccines & Immunotherapeutics covers Immunotherapy research under the subject of Cancer. While Virology is the focus of Human Vaccines & Immunotherapeutics, it also provided insights into the studies of Epitope, Immunity, DNA vaccination and Microbiology.

The research on Pediatrics tackled can also make contributions to studies in the areas of Epidemiology, Incidence (epidemiology) and Disease. In Human Vaccines & Immunotherapeutics, Internal medicine and Adverse effect are investigated in conjunction with one another to address concerns in Immunogenicity research.

  • Vaccination (43.75%)
  • Immunology (33.56%)
  • Virology (24.32%)

What are the most cited papers published in the journal?

  • Vaccine hesitancy: An overview (591 citations)
  • COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. (288 citations)
  • The rationale for quadrivalent influenza vaccines (277 citations)

Research areas of the most cited articles at Human Vaccines & Immunotherapeutics:

The journal articles explore disciplines such as Immunology, Vaccination, Virology, Immune system and Immunogenicity. The journal articles focus on Immunology as well as the interrelated topics of Clinical trial. Immunization, Pediatrics, Family medicine and Environmental health are some topics wherein Vaccination research discussed in the most cited papers has an impact.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Virus

The previous edition focused in particular on these issues:

The discussions in Human Vaccines & Immunotherapeutics mainly cover the fields of Vaccination, Coronavirus disease 2019 (COVID-19), Environmental health, Pandemic and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The journal focuses on Vaccination but the discussions also offer insight into other areas such as Demography, Immunization, Family medicine, Public health and Pediatrics. Pediatrics research featured in the journal incorporates concerns from various other topics such as Epidemiology and Incidence (epidemiology).

The subject of Cross-sectional study, which is connected to the field of Logistic regression, serves as the foundation of the Environmental health research featured in the journal. The study on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presented in the journal intersects with subjects under the field of Virology. Virology works presented in Human Vaccines & Immunotherapeutics have a specific focus on Virus.

The most cited articles from the last journal are:

  • COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. (157 citations)
  • Vaccines and routine immunization strategies during the COVID-19 pandemic. (38 citations)
  • An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. (27 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Human Vaccines & Immunotherapeutics (based on the number of publications) are:

  • Paolo Bonanni (44 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Eva M. Riedmann (38 papers) absent at the last edition,
  • Susanna Esposito (37 papers) absent at the last edition,
  • Fengcai Zhu (32 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Sara Boccalini (29 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Human Vaccines & Immunotherapeutics (based on the number of publications) are:

  • Centers for Disease Control and Prevention (275 papers) published 62 papers at the last edition, 27 more than at the previous edition,
  • Sanofi Pasteur (98 papers) published 10 papers at the last edition the same number as at the previous edition,
  • Chinese Center for Disease Control and Prevention (79 papers) published 16 papers at the last edition, 9 more than at the previous edition,
  • GlaxoSmithKline (74 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Merck & Co. (70 papers) published 16 papers at the last edition, 9 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.84% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.85% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.98% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.58% of all publications and 57.59% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay.

    Li Ping Wong;Haridah Alias;Pooi Fong Wong;Hai Yen Lee

    (2020)
    788 Citations
  • COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey.

    Susan Mary Sherman;Louise E. Smith;Julius Sim;Richard Amlôt;Richard Amlôt

    (2021)
    785 Citations
  • Vaccines and routine immunization strategies during the COVID-19 pandemic.

    Ener Cagri Dinleyici;Ray Borrow;Marco Aurélio Palazzi Safadi;Pierre van Damme

    (2021)
    291 Citations
  • Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?

    Charles Shey Wiysonge;Charles Shey Wiysonge;Duduzile Ndwandwe;Jill Ryan;Anelisa Jaca

    (2021)
    243 Citations
  • Assessing COVID-19 vaccine literacy: a preliminary online survey.

    Luigi Roberto Biasio;Guglielmo Bonaccorsi;Chiara Lorini;Sergio Pecorelli

    (2021)
    219 Citations
  • An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination.

    Musha Chen;Yanjun Li;Jiaoshan Chen;Ziyu Wen

    (2021)
    163 Citations
  • Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.

    Wen Hsiang Chen;Peter J. Hotez;Maria Elena Bottazzi

    (2020)
    137 Citations
  • Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.

    Harapan Harapan;Abram L. Wagner;Amanda Yufika;Wira Winardi

    (2020)
    137 Citations
  • A systematic literature review of herpes zoster incidence worldwide

    Désirée van Oorschot;Hilde Vroling;Eveline Bunge;John Diaz-Decaro

    (2021)
    132 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can open diverse career opportunities in healthcare. Many students begin their journey by enrolling in online medical assistant programs that accept financial aid, which offer flexible options for gaining essential clinical skills without the burden of excessive costs.

To advance further, some pursue a ma to lpn bridge program, designed to transition medical assistants into licensed practical nurses, thus expanding their scope of practice and job prospects.

For a strong foundational knowledge in science, many students opt for an online biology degree. This degree not only supports medical school preparation but also opens doors in research, healthcare technology, and biotechnology sectors.

Lastly, for those committed to nursing, enrolling in asn online nursing programs offers a flexible route to becoming a registered nurse, a critical role in healthcare delivery with diverse specialization options and excellent job stability.

Best Scientists Contributing to This Journal

Recently Published Articles